Wird geladen...
Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma
Fifteen patients with relapsed osteosarcoma were treated with an intensive combination chemotherapy schedule. Ifosfamide 2.5 g m(−2) daily and etoposide 150 mg m(−2) daily coincidentally for 3 days and high-dose methotrexate 8 g m(−2) (with folinic acid rescue) on days 10–14 in a planned 21-day cycl...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Nature Publishing Group
1999
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2362262/ https://ncbi.nlm.nih.gov/pubmed/10098754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690187 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|